FIELD: pharmacology.
SUBSTANCE: invention relates to a compound having the structure:
. The invention also relates to a method for obtaining the specified compound by extraction and isolation from Limax by supercritical CO2 extraction or solvent extraction.
EFFECT: new compound has been obtained that can be used in medicine as a drug to suppress the symptoms of withdrawal syndrome in morphine-dependent animals.
15 cl, 8 dwg, 5 tbl, 10 ex
Authors
Dates
2021-10-27—Published
2019-10-16—Filed